InterCure Ltd. (INCR.TA)
InterCure Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Herzliya, TA, IL. The stock last traded at $282.20, down 0.95% on the session, giving a market capitalisation of $167.1M. Its beta of 0.57 implies it has historically moved less than the broad market.
InterCure Ltd., alongside its affiliated companies, is actively involved in the medical cannabis industry, operating both domestically in Israel and internationally. Their activities encompass the entire spectrum from research and cultivation to production, marketing, and distribution of medical cannabis products. The company's product line features dried cannabis flowers and an oil-based cannabis extract. Additionally, InterCure allocates investments to the biomedical sector. Established in 1994, the firm's main headquarters are situated in Herzliya, Israel.
InterCure Ltd. is most often compared with the following Healthcare names: